Abel De La Rosa - Jan 7, 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role: Director
Signature: /s/ Greg Duncan, Attorney-in-Fact
Stock symbol: VIRI
Transactions as of: Jan 7, 2022
Transactions value $: $23,584
Form type: 4
Date filed: 1/7/2022, 04:24 PM
Previous filing: Jun 23, 2021
Next filing: Jun 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIRI	Common Stock	Purchase	$23.6K	+4K		$5.90^*	4K	Jan 7, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.8375 to $6.00, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.8375 to $6.00, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.